Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,850.00    430.00 (7.93%)
Bid:
6,230.00
Ask:
4,608.00
Spread: -1,622.00 (-26.035%)
Market Cap: $1.42t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Repurchase

18 Mar 2026 08:28

RNS Number : 1318X
Samsung Electronics Co. Ld
18 March 2026
Β 

Decision on Share Repurchase

1.Β Number of shares to be repurchased

Common

37,000,000

Other

-

2.Β Value of shares to be repurchased (Korean won)

Common

7,174,300,000,000

Other

-

3.Β Expected repurchase period

Start date

March 19, 2026

End date

June 18, 2026

4. Expected holding period

Start date

-

End date

-

5.Β Purpose of repurchase

To facilitate employee stock-based compensation

6.Β Method ofΒ repurchase

Open market

7.Β Consignment investment brokers

Samsung Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

8. Holding status of treasury shares before repurchase

Repurchase within the allowable distribution profit (shares)

Common

120,813,769

Ratio (%)

2.0

Other

13,603,461

Ratio (%)

1.7

Other repurchase (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

9.Β Date ofΒ board resolution (confirmation date)

March 18, 2026

-Β Attendance ofΒ Independent Directors at the Board of Directors meeting

Present

5

Absent

-

- Attendance of auditors who are not

Β Independent Directors

-

10.Β Daily order quantity limit

Common

8,656,922

Other

-

Β 

11.Β Other information to consider:

- Shares denoted as "other" are preferred shares.

- In Item 1 above, number of shares to be purchased was calculated based on the closing price on the day prior to the Board's resolution (March 17, 2026).

(KRW 193,900 per common share)

- The Company plans to acquire treasury shares based on the value of shares to be repurchased in Item 2 above. The actual amount may change depending on future stock price movements.

- With respect to Items 4 and Items 5 above, the Company is repurchasing shares that will be held in treasury for use in stock-based compensation programs, including Performance Stock Units (PSUs; introduced in October 2025) as well as in other programs to incentivize employee performance (e.g., OPI, LTI).

- In Item 9 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 10 above is the smaller of: [β‘’] and [the larger of β‘  and β‘‘].

Β β‘  10% of the number of shares to be repurchased: 3,700,000 common

Β β‘‘ 25% of average daily transaction volume over the one month period preceding the date of the board resolution: 8,656,922 common

Β β‘’ 1% of total number of issued shares: 59,196,379 common

Β 

- Limit on the amount of repurchased shares (Korean won)

1.Β Limits toΒ Dividend eligible profit under Commercial Act as of end-2025

243,066,826,669,885

2.Β Amount of repurchased shares since end-2025

6,073,607,225,640

3.Β Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2025

3,753,484,329,311

4.Β The interim dividend amount and related profit reserves decided by the board of directors since end-2025

-

5. Acquisition cost of the shares in disposing of treasury shares since end-2025

826,550,373,780

Limit on the amount of repurchased shares

(1-2-3-4+5)

234,066,285,488,714

- In Item 1 above, 'Limits to Dividend eligible profit under Commercial Act as of end-2025' is based on the 2025 financial statements approved at the general meeting of shareholders as of the report submission date (March 18, 2026)

-In Item 2 above, 'Amount of repurchased shares since end-2025' represents the book value, including related fees and expenses

Β 

- Holding status of treasury shares before purchase (number of shares)

* on-market direct purchase

Stock type

Initial quantity

Changes

End quantity

Purchase

Disposal

Cancellation

Common

91,828,987

36,793,671

7,808,889

-

120,813,769

Other

13,603,461

-

-

-

13,603,461

Β 

* The 'Initial quantity' represents the number of shares held on as of January 1, 2026, the first day of the fiscal year in which the disclosure document was prepared; and the 'End quantity' refers to the number of shares held on March 18, 2026, the day the disclosure document was prepared.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCZZGMFRRDGVZG
Date   Source Headline
30th Jun 202210:01 amRNSSustainability Report 2022
31st May 202211:43 amRNSCorporate Governance Report FY2021
31st May 202211:02 amRNS2022 1Q Interim Business Report
18th May 202210:26 amRNSEarly Termination of Independent Director’s Term
29th Apr 20222:50 pmRNS2021 Business Report
28th Apr 202210:01 amRNSTransactions with Affiliated Companies
28th Apr 20229:49 amRNSTransactions with Affiliated Companies
28th Apr 20229:44 amRNSCharitable Contribution
28th Apr 20229:29 amRNSQuarterly Dividend for First Quarter 2022
28th Apr 20229:24 amRNS2022 1Q Earnings Release
21st Apr 20229:18 amRNSEarly Termination of Independent Director’s Term
21st Apr 20228:49 amRNSEarly Termination of Independent Director’s Term
7th Apr 20229:35 amRNSNotice of 1Q 2022 Earnings Release Schedule
7th Apr 20229:32 amRNS1Q 2022 Pre-Earnings Guidance
16th Mar 20229:10 amRNSTransaction with Affiliate Company
16th Mar 20229:08 amRNSAppointment of New Chief Executive Officer
16th Mar 20229:06 amRNSResults of the 53rd Annual General Meeting
17th Feb 202210:18 amRNSReference Material for 2022 AGM
17th Feb 20228:40 amRNS2021 Separate Financial Statements
17th Feb 20228:30 amRNS2021 Consolidated Financial Statements
15th Feb 202211:35 amRNSReference Material for 2022 AGM
15th Feb 202211:24 amRNSTransaction with Affiliate Company
15th Feb 202211:21 amRNSAppointment of New Chief Executive Officer
15th Feb 202211:16 amRNSCharitable Contribution
27th Jan 20227:05 amRNSYear-End Dividend for FY2021
27th Jan 20227:00 amRNS2021 4Q Earnings Release
7th Jan 20227:00 amRNS4Q 2021 Pre-Earnings Guidance
7th Jan 20227:00 amRNSNotice of 4Q 2021 Earnings Release Schedule
1st Dec 202110:03 amRNSCharitable Contributions
30th Nov 202112:52 pmRNS2021 3Q Interim Business Report
30th Nov 202111:15 amRNSTransactions with Affiliated Companies
24th Nov 20218:11 amRNSInvestment in Fabrication Plant
10th Nov 20217:55 amRNSAnnouncement of Investor Relations Event
28th Oct 20218:22 amRNSCharitable Contribution
28th Oct 20218:18 amRNSTransaction with Affiliate Company
28th Oct 20218:04 amRNSTransaction with Affiliate Company
28th Oct 20218:03 amRNSQuarterly Dividend for Third Quarter 2021
28th Oct 20217:59 amRNS2021 3Q Earnings Release
8th Oct 20218:05 amRNSNotice of 3Q 2021 Earnings Release Schedule
8th Oct 20218:04 amRNS3Q 2021 Pre-Earnings Guidance
31st Aug 202110:39 amRNS2021 Half-year Business Report
29th Jul 20218:12 amRNSRenewal of Property & Casualty Insurance Policy
29th Jul 20218:07 amRNSQuarterly Dividend for Second Quarter 2021
29th Jul 20218:06 amRNS2021 2Q Earnings Release
7th Jul 20218:25 amRNSNotice of 2Q 2021 Earnings Release Schedule
7th Jul 20218:17 amRNS2Q 2021 Pre-Earnings Guidance
6th Jul 202110:04 amRNSSustainability Report 2021
1st Jun 20217:00 amRNS2021 1Q Interim Report
1st Jun 20217:00 amRNSCorporate Governance Report FY2020
20th May 20219:20 amRNS2020 Separate Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.